Protein Tyrosine Phosphatase-1B (PTP-1B) Knockdown Improves Palmitate-induced Insulin Resistance in C2C12 Skeletal Muscle Cells
Overview
Affiliations
Insulin resistance is the central defect in type 2 diabetes and obesity. During the development of insulin resistance a lipid accumulation is accompanied by increased PTP-1B expression in the muscle. The aim of this study was to examine the effects of PTP-1B knockdown on insulin signaling and insulin resistance in the presence or absence of palmitate in C2C12 skeletal muscle cells. A stable C2C12 cell line was established using short hairpin RNA (shRNA) to knockdown protein expression of PTP1B. Analysis of PTP-1B protein expression and phosphorylation and protein levels of IRS-1 and Akt were detected by western blot. The effects of PTP-1B knockdown on the glucose uptake was also measured in C2C12 cells. The stable C2C12 cell line harboring the PTP-1B shRNA showed 62% decrease in the PTP-1B protein levels. 0.5 mM palmitate significantly induced insulin resistance in both control (26%) and PTP-1B knockdown cells (16.5%) compared to the untreated cells. Under treatment with palmitate, insulin stimulated phosphorylation of IRS-1 (Tyr632) and Akt (Ser473) in knockdown cells was significantly 1.55- and 1.86-fold, respectively, greater than the controls. In the presence of palmitate, insulin dependent glucose uptake was significantly about 3-fold higher in PTP-1B knockdown stable C2C12 cells compared to the control cells. Our data showed that decreasing the PTP-1B protein level by shRNA can enhance the activity of important elements of insulin signaling. The improvement in insulin action persisted even in palmitate treated insulin resistant myotubes.
A Novel Role for Protein Tyrosine Phosphatase 1B in Alleviating Chondrocyte Senescence.
Li H, Che X, Tong Z, Wei W, Teng C ACS Omega. 2024; 9(25):27017-27029.
PMID: 38947824 PMC: 11209688. DOI: 10.1021/acsomega.3c10313.
Bai K, Zhu M, Zhang Y, Li X, Chen S, Wang D Front Immunol. 2023; 13:1053856.
PMID: 36618415 PMC: 9815505. DOI: 10.3389/fimmu.2022.1053856.
Li D, Zhang S, Yang C, Li Q, Wang S, Xu X Int J Mol Sci. 2021; 22(23).
PMID: 34884501 PMC: 8657924. DOI: 10.3390/ijms222312693.
Azoramide improves mitochondrial dysfunction in palmitate-induced insulin resistant H9c2 cells.
Okatan E, Olgar Y, Tuncay E, Turan B Mol Cell Biochem. 2019; 461(1-2):65-72.
PMID: 31327095 DOI: 10.1007/s11010-019-03590-z.
Alipourfard I, Datukishvili N, Mikeladze D Mediators Inflamm. 2019; 2019:3560819.
PMID: 30863203 PMC: 6378771. DOI: 10.1155/2019/3560819.